Chularat Hospital PCL (BKK:CHG)
Thailand
· Delayed Price · Currency is THB 1.780
+0.040 (2.30%)
Apr 25, 2025, 11:33 AM ICT
Chularat Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 8,237 | 7,730 | 10,103 | 11,742 | 5,433 | Upgrade
|
| Other Revenue | 243.52 | 284.13 | 304.57 | 257.29 | 28.86 | Upgrade
|
| Revenue | 8,480 | 8,014 | 10,408 | 11,999 | 5,462 | Upgrade
|
| Revenue Growth (YoY) | 5.81% | -22.99% | -13.26% | 119.70% | 5.28% | Upgrade
|
| Cost of Revenue | 6,068 | 5,631 | 5,908 | 5,882 | 3,685 | Upgrade
|
| Gross Profit | 2,413 | 2,384 | 4,500 | 6,117 | 1,777 | Upgrade
|
| Selling, General & Admin | 1,127 | 1,003 | 934.88 | 821.27 | 673.2 | Upgrade
|
| Operating Expenses | 1,127 | 1,003 | 934.88 | 821.27 | 673.2 | Upgrade
|
| Operating Income | 1,286 | 1,381 | 3,565 | 5,296 | 1,104 | Upgrade
|
| Interest Expense | -34.52 | -24 | -16.28 | -21.38 | -35.64 | Upgrade
|
| Interest & Investment Income | 14.11 | 8.66 | 6.08 | 1.9 | 2.77 | Upgrade
|
| Earnings From Equity Investments | -20.07 | -19.35 | -1.11 | - | - | Upgrade
|
| Pretax Income | 1,245 | 1,346 | 3,554 | 5,276 | 1,071 | Upgrade
|
| Income Tax Expense | 267.26 | 279.09 | 703.37 | 1,009 | 218.73 | Upgrade
|
| Earnings From Continuing Operations | 977.96 | 1,067 | 2,850 | 4,267 | 852.36 | Upgrade
|
| Minority Interest in Earnings | -12.74 | -21.21 | -71.68 | -63.22 | 24.26 | Upgrade
|
| Net Income | 965.22 | 1,046 | 2,778 | 4,204 | 876.62 | Upgrade
|
| Net Income to Common | 965.22 | 1,046 | 2,778 | 4,204 | 876.62 | Upgrade
|
| Net Income Growth | -7.73% | -62.35% | -33.91% | 379.58% | 24.30% | Upgrade
|
| Shares Outstanding (Basic) | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 | Upgrade
|
| Shares Outstanding (Diluted) | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 | Upgrade
|
| EPS (Basic) | 0.09 | 0.10 | 0.25 | 0.38 | 0.08 | Upgrade
|
| EPS (Diluted) | 0.09 | 0.10 | 0.25 | 0.38 | 0.08 | Upgrade
|
| EPS Growth | -7.73% | -62.35% | -33.91% | 379.58% | 24.30% | Upgrade
|
| Free Cash Flow | 1,149 | 987.1 | 1,843 | 3,525 | 1,008 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | 0.09 | 0.17 | 0.32 | 0.09 | Upgrade
|
| Dividend Per Share | 0.070 | 0.070 | 0.160 | 0.200 | 0.050 | Upgrade
|
| Dividend Growth | - | -56.25% | -20.00% | 300.00% | - | Upgrade
|
| Gross Margin | 28.45% | 29.74% | 43.23% | 50.98% | 32.54% | Upgrade
|
| Operating Margin | 15.16% | 17.23% | 34.25% | 44.13% | 20.21% | Upgrade
|
| Profit Margin | 11.38% | 13.05% | 26.70% | 35.04% | 16.05% | Upgrade
|
| Free Cash Flow Margin | 13.55% | 12.32% | 17.71% | 29.38% | 18.46% | Upgrade
|
| EBITDA | 1,749 | 1,797 | 3,921 | 5,623 | 1,437 | Upgrade
|
| EBITDA Margin | 20.62% | 22.42% | 37.67% | 46.86% | 26.32% | Upgrade
|
| D&A For EBITDA | 463.31 | 415.65 | 355.71 | 327.11 | 333.37 | Upgrade
|
| EBIT | 1,286 | 1,381 | 3,565 | 5,296 | 1,104 | Upgrade
|
| EBIT Margin | 15.16% | 17.23% | 34.25% | 44.13% | 20.21% | Upgrade
|
| Effective Tax Rate | 21.46% | 20.73% | 19.79% | 19.12% | 20.42% | Upgrade
|
| Revenue as Reported | 8,480 | 8,014 | 10,408 | 11,999 | 5,462 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.